Submission: Department of Health
NTREAP- Evidence For Tranche One
Thursday, 20 February 2020
Natural Therapies Review 2019-2020
Department of Health
By email: email@example.com
Submission – Citations for published scientific research studies for consideration in the Natural Therapies Review 2019-2020
Thank you for the opportunity to make a submission to the Natural Therapies Review 2019-2020.
The Australian Traditional-Medicine Society (ATMS) is Australia’s largest national professional association of natural medicine practitioners. ATMS is a multi-modality association representing around 9,000 accredited practitioners and students throughout Australia. ATMS currently accredits 20 natural medicine modalities.
ATMS promotes and represents accredited practitioners of natural medicine, who are encouraged to pursue the highest ideals of professionalism in their natural medicine practice and education.
ATMS has consistently opposed the process, deliberations and outcomes of the 2015 Review of the Australian Government Rebate on Private Health Insurance for Natural Therapies. We have argued that in the 2015 Review the methodology was flawed and the final Report does not provide a sound basis for Australian public policy.
ATMS supports the process currently underway with the Natural Therapies Review Expert Advisory Panel (NTREAP) 2019-2020. The current call for evidence is for natural medicine therapies identified as tranche 1. Of these therapies ATMS currently accredits:
- western herbal medicine; and
The proposed next call for evidence is for natural medicine therapies identified as tranche 2. Of these therapies ATMS currently accredits:
- Bowen therapy;
- kinesiology; and
Attached is a detailed list of evidence to support both the practice of Naturopathy as well as the tools of trade. Evidence has been provided in the form of abstracts and citations for Naturopathic Practice and the tools of trade for Naturopaths which include Herbal Medicines and Nutritional Supplements. The evidence covers both Systematic Reviews and Meta Analyses as well as Randomised Controlled Trials.
ATMS will make a further submission for tranche 2 when called to do so.
ATMS acknowledges the contribution to this submission by:
The team at Metagenics, specifically Laurence Katsaras and Marla Cunningham